Pay bonanza at Pfizer. Again.
Pfizer Vice Chairman Karen Katen is taking off with $76 million in her pockets, according to the WSJ.
And CEO Jeff Kindler gets a 36% base-pay raise for 2007 and takes home a total compensation valued at $11.4 million for 2006, according to AP.
For some reason Pfizer's sales reps are not amused. More here.
Oh, and by the way, here is Pfizer's share price development over the last five years, compared to the AMEX pharmaceutical index:
Finally, don't miss PharmaGiles' send off of Katen!